Adam Fraser - Chief Operating Officer at Omniscient Neurotechnology (o8t)
Name: Adam Fraser
Position: Chief Operating Officer
Company: Omniscient Neurotechnology (o8t)
Location: Sydney, NSW, Australia
LinkedIn Profile: [Adam Fraser - Omniscient Neurotechnology (o8t) - LinkedIn](https://au.linkedin.com/in/adam-fraser-23202133)
Career Overview
Adam Fraser has over 25 years of varied experience spanning finance, corporate finance, private equity, and technology industries. His career trajectory includes notable roles and achievements:
- Chief Financial Officer (CFO) and Strategy and Corporate Finance at Mortgage Choice (2003-2007):
- Oversaw financial strategies and corporate finance operations.
- Associate Director at Allco Finance Group (2007-2009):
- Managed significant financial operations and strategy implementations.
- Co-founder of an Online Retail Start-Up (2009):
- Entered entrepreneurship with a focus on e-commerce.
- Chief Operating Officer and Chief Financial Officer at PLAUT IT Australia (2011-2019):
- Directed operational and financial activities for a prominent IT service provider.
- Director of Business Transformation at EY (2019-2021):
- Led business transformation initiatives, driving efficiency and growth.
- Founder of EchoJunction:
- Merged social media, marketing, data insights, and enterprise IT to provide innovative solutions.
Current Role at Omniscient Neurotechnology (o8t)
- Chief Financial Officer (May 2021 - Present)
- Responsible for financial oversight and strategic financial planning.
- Chief Operating Officer (April 2023 - Present)
- Manages day-to-day operations and strategic initiatives. Omniscient Neurotechnology (o8t) operates at the cutting edge of brain care, leveraging data science, machine learning, and AI.
Education
- Bachelor of Arts Honors in Economics (1988-1991), University of Nottingham.
- ACA Certification (1992-1996), ICAEW.
- Graduate Diploma in Applied Finance (1997), Securities Institute Australia.
- General Manager Program (2006), AGSM @ UNSW Business School.
Professional Contributions and Achievements
- FDA-clearance for MRI-based Functional Brain Analysis Technology (2022):
- Instrumental in achieving regulatory clearance for new brain mapping technologies, enhancing Omniscient Neurotechnology’s market position.
- Top Prize at the SRS Shark Tank 2024:
- Omniscient Neurotechnology claimed the top prize during the Society of Robotic Surgery’s annual event, showcasing the firm’s innovative advancements in brain mapping technology.
- Published Professional Insights:
- Regularly shares expert insights on platforms like LinkedIn, contributing to the field’s body of knowledge and positioning Omniscient Neurotechnology as a thought leader.
Summary
Adam Fraser’s extensive experience in finance, corporate leadership, and technology, combined with his current role at Omniscient Neurotechnology, underscores his capability to drive strategic growth and innovation. His leadership in achieving FDA-clearance for new technologies and his recognition at industry events like SRS Shark Tank epitomize his impact and forward-thinking approach within the medtech industry.
